Close
American Drug Delivery & Formulation Summit
Xylem

News

Norse Atlantic Airways partners with WebCargo

Norse Atlantic Airways and WebCargo by Freightos, the leading air cargo booking platform announced a significant partnership to offer the European-based carrierโ€™s capacities from the biggest European Union cities for instant eBooking and payment on WebCargo. Norse Atlantic, will soon...

LATAM Cargo Partners with CGM Nuclear

LATAM Airlines Groupโ€™s business unit that specializes in air cargo transportation, including pharmaโ€”is reinforcing its commitment to the battle against cancer by partnering with CGM Nuclear, a producer of radiopharmaceuticals in Chile. The purpose of this collaboration is to...

IAG Cargo expands cold chain services in US

IAG Cargoโ€™s facility at Cincinnati/Northern Kentucky International Airport (CVG) has been approved to transport time and temperature-sensitive healthcare products. This โ€œConstant Climateโ€ station will facilitate the movement of pharmaceuticals that require time and temperature management between Cincinnati and London Heathrow...

Saudia Cargo focuses on pharma

Saudia Cargo is hoping to benefit from increasing pharma demand in the Middle East after seeing volumes in the vertical increase by double-digit percentage levels since 2019. The carrier said that it had experienced 19% annual growth in pharmaceutical shipments...

Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation

Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead program to identify SHP2 degraders.ย  SHP2 is a tyrosine-specific phosphatase implicated in human cancers and the objective is to develop potent bifunctional compounds with excellent ADME and PK...

Global Pharmaceutical Contract Packaging Is On The Rise

Grand View Research's pharmaceutical packaging industry data compilation encompasses market size projections, trade data, pricing intelligence, competitive benchmarks, macro-environmental analysis, and studies on regulatory and technological frameworks. This information is systematically evaluated within the database, and presented in the...

Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment

A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxiaโ€™s drug candidate EVX-101, which is in development for major depressive disorder (MDD). Quotient Sciencesโ€™ Translational...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป